Molecular Characterization of NF1 and Neurofibromatosis Type 1 Genotype-Phenotype Correlations in a Chinese Population

• Published in: Scientific reports Vol. 5; no. 1; p. 11291
• Main Authors: Zhang, Jia, Tong, Hanxing, Fu, Xi’an, Zhang, Yong, Liu, Jiangbo, Cheng, Ruhong, Liang, Jianying, Peng, Jie, Sun, Zhonghui, Liu, Hong, Zhang, Furen, Lu, Weiqi, Li, Ming, Yao, Zhirong
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 09-06-2015; Nature Publishing Group
• Subjects: 45/22; 45/23; 45/90; 45/91; 692/308/2056; 692/700/139/1512; Age; China; Genes, Neurofibromatosis 1; Genetic disorders; Genotype; Humanities and Social Sciences; Humans; multidisciplinary; Mutation; Neurofibromatosis; Neurofibromatosis 1 - genetics; Neurological disorders; Phenotype; Recklinghausen's disease; Science; Science (multidisciplinary); Skin; Tumor suppressor genes; Tumors; China
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep11291

Neurofibromatosis type 1 (
NF1
) is an autosomal dominant hereditary disease that is primarily characterized by multiple café au-lait spots (CALs) and skin neurofibromas, which are attributed to defects in the tumor suppressor
NF1
. Because of the age-dependent presentation of NF1, it is often difficult to make an early clinical diagnosis. Moreover, identifying genetic alterations in NF1 patients represents a complex challenge. Currently, there are no effective detective methods and no comprehensive
NF1
mutation data are available for mainland China. We screened 109 Chinese patients from 100 families with NF1-like phenotypes (e.g., CALs, neurofibromas, etc.) using Sanger sequencing, multiplex ligation-dependent probe amplification and cDNA sequencing.
NF1
mutations were identified in 97 individuals, among which 34 intragenic mutations have not previously been reported. Our exhaustive mutational analysis detected mutations in 89% (89/100) of the NF1-like probands and 93% (70/75) of subjects fulfilling the National Institutes of Health (NIH) criteria. Our findings indicate that individuals who exclusively present with multiple CALs exhibit a high possibility (76%) of having NF1 and show a significantly lower mutation rate (p = 0.042) compared with subjects who fulfill the NIH criteria, providing clinicians with the information that subjects only with multiple CALs harbor a considerable possibility (24%) of being attributed to other comparable diseases.